Last week, SentryX was present at two renowned global conferences: the Global Spine Congress in Prague and the 9th World Congress of the ERAS (Enhanced Recovery After Surgery) Society in Lisbon.

At these events, the company's primary focus was to share updates on the clinical development of their first implantable anesthetic for spine surgery, BR-003. Furthermore, SentryX actively sought input and feedback on the added value of BR-003 in spine surgery from many professionals, including spine surgeons, pain specialists, and global Medtech representatives.

Participating in these conferences provided SentryX with valuable opportunities to contribute to the advancement of spine care and postoperative recovery. The company looks forward to continuing its efforts to improve patient outcomes and help medical technology move forward.